DERENZINI, ENRICO

DERENZINI, ENRICO  

Dipartimento di Scienze della Salute  

Mostra records
Risultati 1 - 20 di 92 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature 2023 Carbonaro, RiccardoMazzocconi, LucaDerenzini, EnricoVeronesi, Paolo + Article (author) -
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 2023 Derenzini, EnricoFederici, Augusto BramanteGuidetti, AnnaCorradini, PaoloPassamonti, Francesco + Article (author) -
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL 2023 Mazzara, SaveriaBotta, FrancescaFiori, StefanoVanazzi, AnnaRadice, TommasoRaimondi, SaraJereczek-Fossa, Barbara AlicjaTarella, CorradoCeci, FrancescoDerenzini, Enrico + Article (author) -
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 2023 Derenzini, Enrico + Article (author) -
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13) 2023 Derenzini, Enrico + Article (author) -
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma] 2023 Francesca BottaEnrico DerenziniTommaso RadiceSaveria MazzaraCorrado TarellaSara RaimondiFrancesco Ceci + Article (author) -
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy 2022 Derenzini, Enrico + Article (author) -
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients 2022 Derenzini, EnricoTarella, Corrado + Article (author) -
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era 2022 Mussetti, AlbertoDerenzini, Enrico + Article (author) -
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma 2022 Mazzara, SaveriaFiori, StefanoDerenzini, Enrico + Article (author) -
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study 2022 Derenzini, EnricoMorelli, EmanuelaPinto, Antonio + Article (author) -
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics 2022 Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + Article (author) -
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade 2022 Mazzara, SaveriaFabbri, MarcoFiori, StefanoLorenzini, DanieleDerenzini, EnricoVanazzi, AnnaTarella, Corrado + Article (author) -
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma 2022 Corradini, PaoloDerenzini, EnricoGuidetti, AnnaPassamonti, FrancescoRambaldi, AlessandroTarella, Corrado + Article (author) -
Plasmablastic lymphoma : One or more tumors? 2021 Mazzara S.Derenzini E. + Article (author) -
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma 2021 Derenzini, EnricoFinazzi, Maria ChiaraRambaldi, AlessandroTarella, Corrado + Article (author) -
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma 2021 Enrico Derenzini + Article (author) -
Peripheral t‐cell lymphoma, not otherwise specified : Clinical manifestations, diagnosis, and future treatment 2021 Lorenzini D.Tarella C.Derenzini E. + Article (author) -
Predictive and prognostic molecular factors in diffuse large b-cell lymphomas 2021 Mazzara S.Derenzini E. + Article (author) -
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 2021 Passamonti F.Fracchiolla N.Corradini P.Derenzini E. + Article (author) -